Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 32,300 shares, a growth of 28.7% from the January 15th total of 25,100 shares. Based on an average trading volume of 246,000 shares, the days-to-cover ratio is currently 0.1 days.
Bioasis Technologies Trading Down 20.5 %
Shares of OTCMKTS BIOAF opened at $0.02 on Tuesday. The stock has a market capitalization of $1.69 million, a PE ratio of -0.71 and a beta of 0.29. The stock's fifty day simple moving average is $0.05 and its two-hundred day simple moving average is $0.10. Bioasis Technologies has a 12-month low of $0.02 and a 12-month high of $0.23.
Get
Bioasis Technologies alerts:
Bioasis Technologies Company Profile
(Get Rating)
biOasis Technologies, Inc operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier.
See Also
- Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
- Should Medtronic's Recent Colibri Patent Controversy Concern You?
- Checkpoint Software Helps Cyber Security Stocks Bottom
- Under Armour Stock, Gap and Crap, Here's Why
- Is Chevron Positioned To Take Energy Sector Leadership?
- What Does the Consumer Price Index Measure?
Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
绿洲生物科技有限公司(BiOasis Technologies Inc.)是1月份空头股数大幅增长的目标。截至1月31日,空头股数共有32,300股,较1月15日的25,100股增长28.7%。以24.6万股的平均成交量计算,目前天数与回补比率为0.1天。
BiOASIS技术公司股价下跌20.5%
周二,OTCMKTS BIOAF的股价开盘报0.02美元。该股市值为169万美元,市盈率为-0.71,贝塔系数为0.29。该股的50日简单移动均线为0.05美元,其200日简单移动均线为0.10美元。BiOasis Technologies的12个月低点为0.02美元,12个月高位为0.23美元。
到达
BiOASIS技术警报:
BiOASIS技术公司简介
(获取评级)
BiOasis Technologies,Inc.是一家生物制药公司。它专注于神经疾病和障碍的诊断和治疗的研究和开发,如脑癌、神经退行性疾病和代谢障碍。它的产品包括作为其专有载体的Transcend计划、p97和跨越血脑屏障的显像剂。
另请参阅
- 免费获取StockNews.com关于BiOASIS技术的研究报告(BIOAF)
- 美敦力最近的Colibri专利争议是否应该引起您的关注?
- Checkpoint软件帮助网络安全类股触底
- 在装甲库存、缺口和垃圾下,这就是为什么
- 雪佛龙做好了引领能源行业的准备吗?
- 消费者物价指数衡量的是什么?
接受《BiOASIS技术日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯,接收最新新闻和分析师对BiOasis Technologies及相关公司的评级的每日摘要。